Annalisa Trama, MD, PhD, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, explains that the incidence of rare cancers is similar in Asia and Europe, which is advantageous for the development of research into these cancers. This interview took place at the European Society for Medical Oncology (ESMO) Asia congress 2022 in Singapore.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.